Pyxis Oncology
PYXS
PYXS
74 hedge funds and large institutions have $30.2M invested in Pyxis Oncology in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less funds holding
Funds holding: 88 → 74 (-14)
48% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 29
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
74
Holding in Top 10
1
Calls
$16K
Puts
$2K
Top Buyers
| 1 | +$1.54M | |
| 2 | +$1.16M | |
| 3 | +$370K | |
| 4 |
SC
Schulhoff & Co
Cincinnati,
Ohio
|
+$168K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$163K |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$821K | |
| 3 | -$658K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$601K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$316K |
